Gary Aston-Jones

Affiliations:

Medical University of South Carolina, Charleston, SC, United States

Area:

neuropharmacology

Google:

"Gary Aston-Jones"

Mean distance: 11.85 (cluster 40)

Tree Publications Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

Parents

James Olds	grad student	MUSC
Stuart H. Thompson	grad student	Stanford
Simon Alford	post-doc	MUSC
Floyd E. Bloom	post-doc	The Salk Institute for Biological Studies

Children

Mathieu E. Wimmer	research assistant	2003-2006	Penn
Rebecca V Fallon	research assistant	2008-2011	MUSC
Noam I. Keren	grad student		MUSC
Mark A Presker	grad student		Rutgers - Robert Wood Johnson Medical School
Elisabeth J. VanBockstaele	grad student		Thomas Jefferson
Alice Hsueh Luo	grad student	2007	Penn
Rachel Joann Smith	grad student	2008	Penn
Gregory C. Sartor	grad student	2007-2011	MUSC
Brandon S. Bentzley	grad student	2014	MUSC
Zackary A. Cope	grad student	2014	MUSC
Brittney M. Cox	grad student	2010-2015	MUSC
Andrea Bari	post-doc		MUSC
Heinrich S. Gompf	post-doc		MUSC
Kirsten A. Porter-Stransky	post-doc		MUSC
Pouya Tahsili-Fahadan	post-doc		Medical University of SC
David Moorman	post-doc	2006-	MUSC
Matthew D. Riedy	post-doc	2009-	MUSC
Elena Maria Vazey	post-doc	2009-	MUSC
Benjamin A. Zimmer	post-doc	2013-	MUSC
Amy S. Kohtz	post-doc	2014-	Rutgers, New Brunswick
Mohsen Omrani	post-doc	2015-	Rutgers, New Brunswick
Michael L. Oshinsky	post-doc	1998-2000	Children’s Hospital of Philadelphia / University of Pennsylvania
Stephen V. Mahler	post-doc	2009-2015	MUSC

Collaborators

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
James MH, Fragale JE, O'Connor SL, et al. (2020) The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol co-abuse. Neuropharmacology. 108359
Fragale JE, James MH, Aston-Jones G. (2020) Intermittent self-administration of fentanyl induces a multifaceted addiction state associated with persistent changes in the orexin system. Addiction Biology. e12946
Freeman LR, Bentzley BS, James MH, et al. (2020) Sex Differences in Demand for Highly Palatable Foods: Role of the Orexin System. The International Journal of Neuropsychopharmacology
James MH, Fragale JE, Aurora RN, et al. (2020) Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
James MH, Aston-Jones G. (2020) Introduction to the Special Issue: "Orexin/hypocretin receptor antagonists for the treatment of addiction and related psychiatric disease: What are the steps from here?" Brain Research. 146665
Gu Y, Piper WT, Branigan LA, et al. (2019) A brainstem-central amygdala circuit underlies defensive responses to learned threats. Molecular Psychiatry
Hamlett ED, Ledreux A, Gilmore A, et al. (2019) Inhibitory designer receptors aggravate memory loss in a mouse model of down syndrome. Neurobiology of Disease. 134: 104616
Mohammadkhani A, Fragale JE, Pantazis CB, et al. (2019) Orexin-1 receptor signaling in ventral pallidum regulates motivation for the opioid remifentanil. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience
Mohammadkhani A, James MH, Pantazis CB, et al. (2019) Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil. Brain Research. 146461
Pantazis CB, James MH, Bentzley BS, et al. (2019) The number of lateral hypothalamus orexin/hypocretin neurons contributes to individual differences in cocaine demand. Addiction Biology. e12795